Puma Biotechnology, Inc. Soared
Tue, Feb 04, 2020 at 05:30 PM
Puma Biotechnology, Inc. (PBYI:NASDAQ) rocketted at $10.58, representing a gain of 31.6%. The stock appeared on our News Catalysts scanner on Tue 21 Jan 20 at 05:38 PM in the 'BIOTECH' category. From Mon 13 Jan 20, the stock recorded 57.14% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Puma Biotechnology, Inc. (PBYI:NASDAQ)
Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.
Top 10 Gainers:
- ContraFect Corporation (CFRX:NASDAQ), 968.49%
- Myomo, Inc. (MYO:NYSEMKT), 114.71%
- iBio, Inc. (IBIO:NYSEMKT), 61.69%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 36.84%
- Puma Biotechnology, Inc. (PBYI:NASDAQ), 31.59%
- Digital Ally, Inc. (DGLY:NASDAQ), 28.13%
- Allot Ltd. (ALLT:NASDAQ), 26.78%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 21.77%
- Aduro BioTech, Inc. (ADRO:NASDAQ), 20.43%
- Blink Charging Co. (BLNK:NASDAQ), 20.29%